Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Columbia Asia Receives...

    Columbia Asia Receives $101M ( Rs 680 cr Appx) Investment from Mitsui & Co.

    Written by savita thakur thakur Published On 2016-07-27T20:09:35+05:30  |  Updated On 18 Aug 2021 12:15 PM IST

    Columbia Asia, one of the largest and healthcare companies in Asia, announced today it is receiving $101 million in investment from Mitsui & Co., Ltd., one of the world's largest and most respected trading companies.


    Columbia Asia, part of Seattle-based Columbia Pacific Management, has 27 hospitals and one clinic in India, Malaysia, Vietnam and Indonesia, built with an innovative business model focused on serving Asia's rapidly growing middle class with modern and efficient multispecialty hospitals located close to where patients live and work.


    Tokyo-based Mitsui & Co., Ltd., already a major healthcare investor in Asia, said it saw tremendous growth potential in the Columbia Asia platform, which is the only healthcare provider in Asia to operate hospitals in so many countries under a single brand, and one of the few large, multinational providers in Asia to build the vast majority of its hospitals itself.


    "Columbia Asia has proven over more than 20 years that it can enter new markets across various countries and develop international, high quality hospitals that meet the needs of the emerging middle class," said Mr. Koji Nagatomi, Managing Officer and Chief Operating Officer, Healthcare & Service Business Unit, Mitsui & Co., Ltd. "The company has also established a firm presence in countries where healthcare spending and insurance coverage are going up at a very rapid pace, which positions the firm well in coming decades."


    Columbia Asia will use the proceeds from the Mitsui investment to continue to expand its network of hospitals across Asia, including several current development projects. In addition, the company will open its first facility in Africa next month, a multispecialty clinic in Nairobi, Kenya under a new brand, Columbia Africa.


    Since opening its first hospital in Malaysia in 1996, Columbia Asia has focused on providing high quality, affordable, standardized care in hospitals built on a single design.


    The company currently has 10,000 employees serving more than 2.5 million patients a year, with 2,200 beds across 27 hospitals and one clinic.


    As part of its investment, Mitsui will gain two seats on the Columbia Asia Board of Directors and play a role in company operations.


    Mitsui is also using the investment to expand its hospitals business as the core of its healthcare strategy and will look to form partnerships between Columbia Asia and some of the other healthcare companies in which Mitsui is an investor. These include IHH Healthcare Berhad, the largest healthcare company in Asia; MIMS Group, which provides drug information to about 2 million healthcare professionals in Asia-Oceania; and DaVita Care Pte. Ltd., the Asian operating company for the largest dialysis operator in the U.S.


    "We are thrilled to partner with Mitsui and share in its expertise in not just healthcare operations across Asia but its vast business operations in 65 countries on multiple continents," said Nate McLemore, Managing Director of Columbia Asia's parent company, Columbia Pacific Management. "Mitsui is one of the most sophisticated and respected investors in the world, and we are proud that the company is part of Columbia Asia going forward."

    Columbia AsiaColumbia Pacific ManagementDaVitaHealthcare & Service Business UnitIHH Healthcare BerhadInvestmentMitsui & Co.Mr Koji NagatomiNate McLemore
    Source : Press Release

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    savita thakur thakur
    savita thakur thakur
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok